Long-term cure of soft tissue sarcoma with pegylated-liposomal doxorubicin after doxorubicin and ifosfamide failure

BACKGROUND: Doxorubicin is one of the most active drugs available for the treatment of sarcoma. Pegylated-liposomal doxorubicin (PLD) is a formulation of doxorubicin in which the doxorubicin is encapsulated in liposomes coated with methoxypoly (ethylene glycol); this formulation results in decreased...

Descripción completa

Detalles Bibliográficos
Autores principales: Savani, Malvi, Murugan, Paari, Skubitz, Keith M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332634/
https://www.ncbi.nlm.nih.gov/pubmed/30651969
http://dx.doi.org/10.1186/s13569-018-0111-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332634/
https://www.ncbi.nlm.nih.gov/pubmed/30651969
http://dx.doi.org/10.1186/s13569-018-0111-0

Ejemplares similares